Clinical trial
A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid…
NCT00406419 · Genentech, Inc., Industry · Terminated
Key facts
| NCT number | NCT00406419 |
|---|---|
| Title | A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE) |
| Official title | A Randomized, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment |
| Acronym | STAGE |
| Lead sponsor | Genentech, Inc., Industry |
| Collaborators | Roche Pharma AG Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Methotrexate, ocrelizumab, Placebo |
| Enrollment | 1,015 |
| Start date | Dec 27, 2006 |
| Primary completion | Oct 6, 2009 |
| Completion | Apr 22, 2015 |
| First posted | Dec 4, 2006 |
| Last update posted | Nov 27, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: